It is a pharma private limited company based in Cuddapah, Andhra Pradesh, India, established in 2017.
2017 | Cuddapah, Andhra Pradesh, India | ActivePreside Pharmaceutical Private Limited, a active private limited company, was established on 29 December 2017 in Cuddapah, Andhra Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999AP2017PTC107359. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Eragam Reddy Vijaya (Director), Eragam Reddy Naga Praveen Kumar Reddy (Director). Past directors included Darga Mallikarjuna, Eragam Reddy Naga Praveen Kumar Reddy. It holds ₹1.48 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No. 5/69 Muttarasupally, Cuddapah, Andhra Pradesh, 516002.
U74999AP2017PTC107359
107359
29 December 2017
₹0.10 M
₹0.10 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Preside Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Eragam Reddy Vijaya | Director | 10 Mar 2021 | Current |
| Eragam Reddy Naga Praveen Kumar Reddy | Director | 29 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Mar 2021 | Past |
| Pramod Abcsdd | Director | 09 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Preside Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 81.89% increase. The company also saw a substantial improvement in profitability, with a 95.93% increase in profit. The company's net worth dipped by a decrease of 3.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Preside Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,475,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2025 | The South Indian Bank Limited | ₹1.48 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Preside Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Preside Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Preside Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with The South Indian Bank Limited amounted to Rs. 1.48 M with Charge ID 101155609 was registered on 21 Aug 2025. was recorded as a recent event.
Progress on Preside Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Preside Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was documented.
Progress on Eragam Reddy Vijaya was appointed as a Director was appointed as a Director on 10 Mar 2021 & has been associated with this company since 4 years 8 months . was documented.
Eragam Reddy Naga Praveen Kumar Reddy was appointed as a Director was appointed as a Director on 29 Dec 2017 & has been associated with this company since 7 years 10 months . was recorded as a recent event.
Progress on Preside Pharmaceutical Private Limited was registered on 29 Dec 2017 with Roc Vijayawada & aged 7 years 10 months as per MCA records. was documented.
The CIN of Preside Pharmaceutical Private Limited is U74999AP2017PTC107359.
Preside Pharmaceutical Private Limited is headquartered at D.No. 5/69 Muttarasupally, Cuddapah, Andhra Pradesh, 516002.
Preside Pharmaceutical Private Limited was incorporated on 29 December 2017.
The current directors of Preside Pharmaceutical Private Limited are
The primary industry of Preside Pharmaceutical Private Limited is Pharma.
Preside Pharmaceutical Private Limited is unlisted.
The authorized capital of Preside Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Preside Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX